Market Cap : 744.82 M | Enterprise Value : 611.45 M | PE Ratio : At Loss | PB Ratio : 1.19 |
---|
NAS:SLGC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SLGC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. SomaLogic's quick ratio for the quarter that ended in Jun. 2022 was 18.26.
SomaLogic has a quick ratio of 18.26. It generally indicates good short-term financial strength.
The historical rank and industry rank for SomaLogic's Quick Ratio or its related term are showing as below:
During the past 2 years, SomaLogic's highest Quick Ratio was 31.83. The lowest was 12.64. And the median was 23.83.
The historical data trend for SomaLogic's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, SomaLogic's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's Quick Ratio distribution charts can be found below:
* The bar in red indicates where SomaLogic's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
SomaLogic's Quick Ratio for the fiscal year that ended in Dec. 2021 is calculated as
Quick Ratio (A: Dec. 2021 ) | = | (Total Current Assets | - | Total Inventories) | / | Total Current Liabilities |
= | (691.552 | - | 11.213) | / | 29.285 | |
= | 23.23 |
SomaLogic's Quick Ratio for the quarter that ended in Jun. 2022 is calculated as
Quick Ratio (Q: Jun. 2022 ) | = | (Total Current Assets | - | Total Inventories) | / | Total Current Liabilities |
= | (658.709 | - | 20.768) | / | 34.931 | |
= | 18.26 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Thank you for viewing the detailed overview of SomaLogic's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Blakeman Shaun M. | officer: Chief Financial Officer | C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424 |
Margulies Anne H. | director | C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747 |
Post Richard A | director | 998 LACOSTA LANE LANE TREE CO 80124 |
Casdin Eli | director | 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019 |
Cox Troy | director | C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141 |
Meisel Ted D | director | |
Barchi Robert | director | |
Quake Stephen | director | C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080 |
Lillis Charles M. | director | 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108 |
Harris Melody | officer: President and COO | 4801 WEST BYRON PLACE DENVER CO 80211 |
Gutierrez Ruben | officer: General Counsel | 6435 AVENIDA WILFREDO LA JOLLA CA 92037 |
Graves Amy | officer: Chief Accounting Officer | 926 PENDLETON AVENUE LONGMONT CO 80504 |
Smythe Roy | director, officer: Chief Executive Officer | 935 10TH STREET BOULDER CO 80302 |
M-lsh Ii Llc | 10 percent owner | 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065 |
C-lsh Ii Llc | 10 percent owner | 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019 |
From GuruFocus
Other Sources
By Zacks 2022-02-17
By Seekingalpha 2022-01-11
By Seekingalpha 2021-11-15
By Seekingalpha 2021-10-14